November 9, 2022 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

November 17, 2023 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)See more

November 17, 2023 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

Veru Stock: Advisory Committee Vote 8-5 that Risk Outweighs BenefitSee more

Veru Stock: Advisory Committee Vote 8-5 that Risk Outweighs Benefit

Actual